MedPath

Clinical study on the treatment of infantile intrahepatic cholestasis liver disease of low ? - glutamyltranspeptidase type based on the theory of liver collateral disease of traditional Chinese Medicine

Phase 1
Recruiting
Conditions
Clinical study of intrahepatic cholestatic liver disease in infants
Registration Number
ITMCTR2000003356
Lead Sponsor
Beijing Children's Hospital Affiliated to Capital Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who meet the diagnostic criteria of cholestatic liver disease in infants;
2.?-GGT<100 U/L
3. According to the diagnosis standard of traditional Chinese medicine, refer to the 2018 clinical diagnosis and treatment guide for pediatrics of traditional Chinese medicine · fetal yellow (Revised) for patients with syndrome of stasis and yellow;
4. Children with complete cases.

Exclusion Criteria

1. Patients with biliary tract malformation;
2. Patients with other organ and system diseases;
3. Patients with major organ failure.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.